CYTK vs JKHY · rev $28.6M vs P/E 30, rev $2.54B
Cytokinetics Inc (CYTK) versus Jack Henry & Associates Inc (JKHY) — a side-by-side from cached financials, not a winner call.
Cytokinetics Inc (CYTK) is a biotechnology company listed on US.
Jack Henry & Associates Inc (JKHY) is a information technology services company listed on US.
Latest reported CYTK revenue for 2026-06-30 was $28.6M. Net income was -$198.8M. Revenue was up 47.9% from 2026-03-31 to 2026-06-30. CYTK currently screens at market cap $4.05B.
Latest reported JKHY revenue for 2026-06-30 was $2.54B. Net income was $502.8M. Revenue was up 7.1% from 2025-06-30 to 2026-06-30. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
CYTK currently screens at market cap $4.05B. JKHY currently screens at market cap $12.76B and trailing P/E 29.8.
Not investment advice. Open the CYTK and JKHY stock pages for the full models.
Not investment advice.